United States (US) Healthcare-Associated Infection (HAI) Market (2025-2031) | Share, Industry, Companies, Trends, Segmentation, Outlook, Size & Revenue, Competitive Landscape, Growth, Forecast, Analysis, Value

Market Forecast By Product (Consumables, Analyzers/Instruments), By Pathogen (Viral, Bacterial, Fungal), By Treatment (Sterilization, Chemical, Radiation), By Infections (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, BloodStream Infections, Gastrointestinal Infections, Respiratory Infections, Others), By Diagnostic Tests (Traditional Diagnostics, Molecular Diagnostics), By End Use (Hospitals, Clinics, ASCs, Others) And Competitive Landscape
Product Code: ETC9967476 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Healthcare-Associated Infection (HAI) Market Outlook
  • Market Size of United States (US) Healthcare-Associated Infection (HAI) Market, 2024
  • Forecast of United States (US) Healthcare-Associated Infection (HAI) Market, 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Revenues & Volume for the Period 2021- 2031
  • United States (US) Healthcare-Associated Infection (HAI) Market Trend Evolution
  • United States (US) Healthcare-Associated Infection (HAI) Market Drivers and Challenges
  • United States (US) Healthcare-Associated Infection (HAI) Price Trends
  • United States (US) Healthcare-Associated Infection (HAI) Porter's Five Forces
  • United States (US) Healthcare-Associated Infection (HAI) Industry Life Cycle
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Consumables for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Analyzers/Instruments for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Pathogen for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Viral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Bacterial for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Fungal for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Sterilization for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Chemical for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Radiation for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Urinary Tract Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Surgical Site Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Hospital-acquired Pneumonia for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By BloodStream Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Gastrointestinal Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Respiratory Infections for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Diagnostic Tests for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Traditional Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Molecular Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By End Use for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By ASCs for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Healthcare-Associated Infection (HAI) Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Pathogen
  • Market Opportunity Assessment By Treatment
  • Market Opportunity Assessment By Infections
  • Market Opportunity Assessment By Diagnostic Tests
  • Market Opportunity Assessment By End Use
  • United States (US) Healthcare-Associated Infection (HAI) Top Companies Market Share
  • United States (US) Healthcare-Associated Infection (HAI) Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Healthcare-Associated Infection (HAI) Company Profiles
  • United States (US) Healthcare-Associated Infection (HAI) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Healthcare-Associated Infection (HAI) Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Healthcare-Associated Infection (HAI) Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Healthcare-Associated Infection (HAI) Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Healthcare-Associated Infection (HAI) Market - Industry Life Cycle

3.4 United States (US) Healthcare-Associated Infection (HAI) Market - Porter's Five Forces

3.5 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Pathogen, 2021 & 2031F

3.7 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.8 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Infections, 2021 & 2031F

3.9 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By Diagnostic Tests, 2021 & 2031F

3.10 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume Share, By End Use, 2021 & 2031F

4 United States (US) Healthcare-Associated Infection (HAI) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of healthcare-associated infections in the US

4.2.2 Growing awareness about the importance of infection prevention and control

4.2.3 Technological advancements in healthcare facilities improving infection prevention measures

4.3 Market Restraints

4.3.1 Stringent regulations and guidelines for infection control increasing operational costs for healthcare facilities

4.3.2 Limited reimbursement for infection prevention measures impacting adoption rates

4.3.3 Shortage of skilled healthcare professionals specialized in infection prevention

5 United States (US) Healthcare-Associated Infection (HAI) Market Trends

6 United States (US) Healthcare-Associated Infection (HAI) Market, By Types

6.1 United States (US) Healthcare-Associated Infection (HAI) Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Consumables, 2021- 2031F

6.1.4 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Analyzers/Instruments, 2021- 2031F

6.2 United States (US) Healthcare-Associated Infection (HAI) Market, By Pathogen

6.2.1 Overview and Analysis

6.2.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Viral, 2021- 2031F

6.2.3 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Bacterial, 2021- 2031F

6.2.4 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Fungal, 2021- 2031F

6.3 United States (US) Healthcare-Associated Infection (HAI) Market, By Treatment

6.3.1 Overview and Analysis

6.3.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Sterilization, 2021- 2031F

6.3.3 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Chemical, 2021- 2031F

6.3.4 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Radiation, 2021- 2031F

6.4 United States (US) Healthcare-Associated Infection (HAI) Market, By Infections

6.4.1 Overview and Analysis

6.4.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F

6.4.3 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Surgical Site Infections, 2021- 2031F

6.4.4 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Hospital-acquired Pneumonia, 2021- 2031F

6.4.5 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By BloodStream Infections, 2021- 2031F

6.4.6 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Gastrointestinal Infections, 2021- 2031F

6.4.7 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Respiratory Infections, 2021- 2031F

6.5 United States (US) Healthcare-Associated Infection (HAI) Market, By Diagnostic Tests

6.5.1 Overview and Analysis

6.5.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Traditional Diagnostics, 2021- 2031F

6.5.3 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F

6.6 United States (US) Healthcare-Associated Infection (HAI) Market, By End Use

6.6.1 Overview and Analysis

6.6.2 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Hospitals, 2021- 2031F

6.6.3 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Clinics, 2021- 2031F

6.6.4 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By ASCs, 2021- 2031F

6.6.5 United States (US) Healthcare-Associated Infection (HAI) Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Healthcare-Associated Infection (HAI) Market Import-Export Trade Statistics

7.1 United States (US) Healthcare-Associated Infection (HAI) Market Export to Major Countries

7.2 United States (US) Healthcare-Associated Infection (HAI) Market Imports from Major Countries

8 United States (US) Healthcare-Associated Infection (HAI) Market Key Performance Indicators

8.1 Rate of compliance with infection prevention protocols in healthcare facilities

8.2 Number of reported healthcare-associated infections in the US

8.3 Investment in research and development for new infection prevention technologies

9 United States (US) Healthcare-Associated Infection (HAI) Market - Opportunity Assessment

9.1 United States (US) Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Pathogen, 2021 & 2031F

9.3 United States (US) Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.4 United States (US) Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Infections, 2021 & 2031F

9.5 United States (US) Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By Diagnostic Tests, 2021 & 2031F

9.6 United States (US) Healthcare-Associated Infection (HAI) Market Opportunity Assessment, By End Use, 2021 & 2031F

10 United States (US) Healthcare-Associated Infection (HAI) Market - Competitive Landscape

10.1 United States (US) Healthcare-Associated Infection (HAI) Market Revenue Share, By Companies, 2024

10.2 United States (US) Healthcare-Associated Infection (HAI) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All